Citadel Advisors
OKYO

Citadel Advisors’s OKYO Pharma OKYO Stock Holding History

Citadel Advisors’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,355
Closed -$30.7K – 13673
2025
Q3 		$30.7K Buy
+15,355
New +$39.1K ﹤0.01% 12387
2025
Q2 		– Sell
-27,404
Closed -$34.8K – 14329
2025
Q1 		$34.8K Buy
27,404
+6,675
+32% +$7.98K ﹤0.01% 12671
2024
Q4 		$23.8K Buy
20,729
+5,853
+39% +$6.28K ﹤0.01% 13059
2024
Q3 		$15.3K Buy
+14,876
New +$17.2K ﹤0.01% 12971
2023
Q4 		– Sell
-15,943
Closed -$29.5K – 14946
2023
Q3 		$29.5K Buy
+15,943
New +$26.8K ﹤0.01% 12279
2022
Q3 		– Sell
-26,864
Closed -$54K – 13306
2022
Q2 		$54K Buy
+26,864
New +$60.4K ﹤0.01% 11889

Other funds holding OKYO

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's OKYO Position: Q4 2025 in Review

Citadel Advisors sold out of OKYO Pharma (OKYO) in Q4 2025, closing a stake of 15,355 shares — an estimated $30.7K sold.

Citadel Advisors first reported a position in OKYO in Q2 2022 and held it in 6 quarters. The position peaked at $54K in Q2 2022. 10 funds tracked by Wall St. Rank hold OKYO as of Q4 2025.

  • Citadel Advisors reported no remaining OKYO Pharma position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 15,355 OKYO Pharma shares in Q4 2025, an estimated $30.7K.
  • Citadel Advisors first reported a position in OKYO Pharma in Q2 2022 and held it in 6 quarters.
  • Citadel Advisors's OKYO Pharma position peaked at $54K in Q2 2022.
  • 10 funds tracked by Wall St. Rank held OKYO Pharma as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.